key: cord-0769035-ebs9c67l
authors: Yahalomi, Tal; Pikkel, Joseph; Arnon, Roee; Pessach, Yuval
title: Central retinal vein occlusion in a young healthy COVID-19 patient: A case report
date: 2020-11-16
journal: Am J Ophthalmol Case Rep
DOI: 10.1016/j.ajoc.2020.100992
sha: 5d93fde9f5dcdb5daf8469bb7e9d4d9510f80320
doc_id: 769035
cord_uid: ebs9c67l

PURPOSE: We detail a unique case of a healthy 33-year-old suspected COVID-19 patient who presented with unilateral Central Retinal Vein Occlusion, possibly as a complication of COVID-19. OBSERVATIONS: A 33-year-old healthy male was referred to the emergency department due to blurred vision in his left eye for the past month, accompanied by flashes of light without any accompanying neurological symptoms. The patient reported a three-week period of fatigue, dry cough, and shortness of breath ended about 2 weeks prior to the ocular symptoms. He was not tested for COVID-19 at the time of his respiratory complaints. The clinical examination and the ancillary tests confirmed the diagnosis of a left eye Central Retinal Vein Occlusion. During admission, a real-time reverse transcription-polymerase chain reaction (RT-PCR) for SARS-CoV-2 from a nasopharyngeal swab was performed and was found to be negative, however, an IgG/IgM Rapid Test (Inzek International Trading, the Netherlands) was performed and was found to be IgM negative and IgG Positive for SARS-CoV-2, confirming recovery from COVID-19. CONCLUSIONS AND IMPORTANCE: To the best of our knowledge this is the first report of CRVO in association with COVID-19. As the literature on human ocular manifestations of COVID-19 is still sparse, our case emphasizes the need for further investigation of ocular complication associated with this novel disease.

Coronavirus disease (COVID-19), has been declared by the World Health 53 Organization (WHO) as a pandemic on March 11 th 2020. 1

As of september 13 th 2020, more than 28 million cases have been reported globally 55 resulting in more than 900,000 deaths. 2

The most common symptoms of COVID-19 include fever, dyspnea, dry cough, and The occurrence of CRVO among persons under 50 years of age is considered to be 79 rare and has been reported to be less than 1.5 cases per year at a single institution, or ischemic CRVO (Figures 2A and 2B) . The occurrence of CRVO in adults under 60 years of age has been reported to be 137 considerably less common than in older patients. Systemic hypertension was found to 138 be the most prevalent risk factor for CRVO in young patients, followed by diabetes 

WHO Director-General's opening remarks at the media briefing on COVID-19

general-s-opening-remarks-at-the-media-briefing-on-covid

WHO Coronavirus Disease (COVID-19) Dashboard | WHO Coronavirus 211

Coronavirus disease 2019 (COVID-19): A 214 literature review

Novel Coronavirus Pandemic: What Do 217

Risk Factors Associated With Acute Respiratory 220

Distress Syndrome and Death in Patients With Coronavirus Disease

COVID-19 and Thrombotic or

 The following authors have no financial disclosures: TY ,YP, TBN,